These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 2977029

  • 1. [Hemodynamic, anti-ischemic, metabolic and neurohumoral effects of enoximone (MDL 17,043) in patients with coronary disease].
    Mitrovic V, Schlepper M, Neuzner J, Bahavar H, Volz M, Dieterich HA.
    Z Kardiol; 1988 Oct; 77(10):660-7. PubMed ID: 2977029
    [Abstract] [Full Text] [Related]

  • 2. [Neurohumoral and hemodynamic effects in combination therapy of enoximone and dopamine].
    Mitrovic V, Neuzner J, Opper H, Thormann J, Schlepper M.
    Z Kardiol; 1994 Oct; 83 Suppl 2():37-48. PubMed ID: 8091823
    [Abstract] [Full Text] [Related]

  • 3. [Comparison of new cardiac agents using differential therapeutic criteria].
    Redmann K, Lunkenheimer PP, Rettig G, Isringhaus H, Flameng W, Demeyere R.
    Z Kardiol; 1991 Oct; 80 Suppl 4():7-14. PubMed ID: 1833902
    [Abstract] [Full Text] [Related]

  • 4. [Effects of R80122. The influence of a new phosphodiesterase inhibitor on global and intestinal hemodynamics in coronary surgery patients].
    Lange H, Stephan H, Autschbach R, Lueerssen K, Zielmann S, Sonntag H.
    Anaesthesist; 1992 Aug; 41(8):474-80. PubMed ID: 1524159
    [Abstract] [Full Text] [Related]

  • 5. [Enoximone: hemodynamic effect in patients with cardiac insufficiency].
    de Langenhagen B, Bouchoucha H, Scholl JM, Hennetier G, Benacerraf A, Achard F, Bock F.
    Arch Mal Coeur Vaiss; 1990 Sep; 83 Spec No 3():19-25. PubMed ID: 2147830
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Anti-ischemia effects of gallopamil and esmolol in an intra-individual comparison in patients with coronary heart disease].
    Mitrovic V, Oehm E, Minge C, Thürmann P, Schlepper M.
    Z Kardiol; 1994 Jun; 83(6):431-8. PubMed ID: 7915067
    [Abstract] [Full Text] [Related]

  • 8. [Enoximone in the hemodynamic evaluation before heart transplantation. A new test].
    Pornin M, Allal J, Bouton S, Farge D, Couetil JP, Dreyfus G, Sarkis A, Prevost D, Barraine R, Ourbak P.
    Arch Mal Coeur Vaiss; 1990 Sep; 83 Spec No 3():95-101. PubMed ID: 2147842
    [Abstract] [Full Text] [Related]

  • 9. Low-dose enoximone therapy in pre-transplant patients: hemodynamic, echocardiographic, and neurohumoral findings.
    Park JW, Heinzler R, Wirtz JH, Fieten-Rumswinkel M, Braun P, May E, Hetzer R, Heinrich KW.
    Z Kardiol; 1994 Sep; 83 Suppl 2():49-53. PubMed ID: 8091824
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Enoximone (MDL 17,043), a phosphodiesterase inhibitor, in the treatment of advanced, unstable chronic heart failure.
    Weber KT, Janicki JS, Jain MC.
    J Heart Transplant; 1986 Sep; 5(2):105-12. PubMed ID: 2956397
    [Abstract] [Full Text] [Related]

  • 12. [Postoperative enoximone in coronary surgery. Systemic and coronary hemodynamics and regional systolic function].
    Payen D, Dupuy P, Schurando P, Laborde F.
    Arch Mal Coeur Vaiss; 1990 Sep; 83 Spec No 3():13-7. PubMed ID: 2147829
    [Abstract] [Full Text] [Related]

  • 13. Peripheral and cardiac effects of a new phosphodiesterase inhibitor in comparison with enoximone.
    Schröder T, Hering JP, Foth H, Ferrari M, Sipinková I, Hellige G.
    Arzneimittelforschung; 1994 Aug; 44(8):948-50. PubMed ID: 7945538
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Hemodynamic, antiischemic, and neurohumoral effects of enoximone in patients with coronary artery disease.
    Mitrovic V, Thormann J, Neuzner J, Bahawar H, Volz M, Dieterich HA, Schlepper M.
    Am Heart J; 1989 Jan; 117(1):106-11. PubMed ID: 2563185
    [Abstract] [Full Text] [Related]

  • 16. [Treatment of chronic cardiac insufficiency with intravenous bolus enoximone. Study of a pharmacokinetic-hemodynamic relation].
    Gibelin P, Garraffo R, Sbirrazzuoli V, Lapalus P, Morand P.
    Arch Mal Coeur Vaiss; 1990 Sep; 83 Spec No 3():75-81. PubMed ID: 2147839
    [Abstract] [Full Text] [Related]

  • 17. [The anti-ischemic effect of phosphodiesterase III inhibitors].
    Schlepper M.
    Z Kardiol; 1994 Sep; 83 Suppl 2():27-36. PubMed ID: 8091822
    [Abstract] [Full Text] [Related]

  • 18. Antiischemic and hemodynamic effects of an oral single dose of 150 mg of the phosphodiesterase inhibitor enoximone in patients with coronary artery disease--relation to plasma concentration.
    Mitrovic V, Petrovic O, Bahavar H, Neuzner J, Dieterich HA, Schlepper M.
    Cardiovasc Drugs Ther; 1991 Aug; 5(4):689-95. PubMed ID: 1832289
    [Abstract] [Full Text] [Related]

  • 19. [Alinidine in multi-vessel coronary disease: reduction of stress-induced ischemic reaction].
    Ditter H, Müller KD, Bahavar H, Schlepper M.
    Z Kardiol; 1991 Feb; 80(2):167-70. PubMed ID: 2058248
    [Abstract] [Full Text] [Related]

  • 20. [Peripheral hemodynamics and metabolic parameters influenced by amrinone at rest and following handgrip stress].
    Peters P, Saborowski F, Griebenow R.
    Z Kardiol; 1986 Dec; 75(12):751-6. PubMed ID: 3825225
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.